Nyack Hospital experimental study finds racial differences in optimal dosing of antibiotic used for critically ill patients

A new experimental study by Nyack Hospital's Clinical Pharmacy Manager finds racial differences in the optimal dosing of the antibiotic doripenem in critically ill patients. The study, led by Andras Farkas, PharmD., suggests the need for more aggressive dosing of the drug in patients of Hispanic descent. The findings will be presented at the Infectious Disease Society of America Annual Meeting, held in San Francisco from October 2-6, 2013, by Nyack infectious disease specialist Dr. Kenneth Rowin...